Dingcheng Gao
9PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 07, 2025
Oligo-CALL: A next-generation barcoding platform for studying resistance to targeted therapy.Yingzhuo Liu, Yi Ban, Dingcheng Gao
|Sep 26, 2024
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy.Geoffrey J Markowitz, Yi Ban, Diamile A Tavarez
|Sep 11, 2024
Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer.Yi Ban, Yue Zou, Yingzhuo Liu
|Jul 10, 2023
Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer.Yi Ban, Yue Zou, Yingzhuo Liu
|Jan 09, 2023
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz
|Feb 05, 2022
Author Correction: Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer.Yi Ban, Geoffrey J Markowitz, Yue Zou
Pageof 2
Frequent Collaborators
5 joint publications
Vivek Mittal
4 joint publications
Nasser K Altorki
4 joint publications
Geoffrey J Markowitz
2 joint publications
Olivier Elemento
2 joint publications
Juan R Cubillos-Ruiz
2 joint publications
Timothy E McGraw
2 joint publications
Yi Ban
2 joint publications
Tito A Sandoval
2 joint publications
Stephen T C Wong
1 joint publications
Yingzhuo Liu
